Licensing Strategy & Implementation
A small biotechnology company with promising oncology product candidates in Phase III and Phase I of clinical trials needs immediate funding for on-going clinical development efforts and also seeks to establish strategic relationships that will better position them for a near-to-mid-term IPO. Boston Healthcare identifies a target list of potential partners, initiates discussions with these potential partners, establishes and negotiates the financial terms, and is instrumental in closing a $97 million deal with a large, multi-national pharmaceutical company for both products for our client. With the partner relationship helping to validate the client’s core intellectual property, the client is able to raise an additional $16 million with a successful IPO.